The “common” and “autoimmune-specific” IFN signatures clearly distinguished between patients with SLE and viral infection at the molecular level and, therefore, are of potential interest as biomarkers to enable the differentiation between SLE flares and viral infections. This evidence concerns the gene IFNA1 and viral infectious disease.